- Home
- BXP vs MEDP Comparison
BXP vs MEDP Comparison
Compare BXP & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXP
- MEDP
- Stock Information
- Founded
- BXP 1970
- MEDP 1992
- Country
- BXP United States
- MEDP United States
- Employees
- BXP N/A
- MEDP N/A
- Industry
- BXP Real Estate Investment Trusts
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BXP Real Estate
- MEDP Health Care
- Exchange
- BXP Nasdaq
- MEDP Nasdaq
- Market Cap
- BXP 11.7B
- MEDP 13.4B
- IPO Year
- BXP 1997
- MEDP 2016
- Fundamental
- Price
- BXP $77.77
- MEDP $501.94
- Analyst Decision
- BXP Hold
- MEDP Hold
- Analyst Count
- BXP 16
- MEDP 11
- Target Price
- BXP $75.63
- MEDP $424.10
- AVG Volume (30 Days)
- BXP 1.8M
- MEDP 310.5K
- Earning Date
- BXP 10-28-2025
- MEDP 10-20-2025
- Dividend Yield
- BXP 5.04%
- MEDP N/A
- EPS Growth
- BXP N/A
- MEDP 26.42
- EPS
- BXP 0.03
- MEDP 13.46
- Revenue
- BXP $3,410,208,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- BXP $2.65
- MEDP $19.06
- Revenue Next Year
- BXP $2.56
- MEDP $8.64
- P/E Ratio
- BXP $2,798.05
- MEDP $37.27
- Revenue Growth
- BXP 2.91
- MEDP 9.94
- 52 Week Low
- BXP $54.22
- MEDP $250.05
- 52 Week High
- BXP $90.11
- MEDP $506.55
- Technical
- Relative Strength Index (RSI)
- BXP 63.80
- MEDP 66.43
- Support Level
- BXP $71.19
- MEDP $485.54
- Resistance Level
- BXP $79.33
- MEDP $506.55
- Average True Range (ATR)
- BXP 2.12
- MEDP 12.72
- MACD
- BXP 0.31
- MEDP -1.23
- Stochastic Oscillator
- BXP 80.86
- MEDP 89.64
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.